Allfudo'n Llwyddiannus — 

Outcomes of patients with myelodysplastic syndromes who achieve stable disease after treatment with hypomethylating agents

Treatment with hypomethylating agents (HMAs) improves overall survival (OS) in patients who achieve a response of stable disease (SD) or better (complete remission [CR], partial remission [PR], or hematologic improvement [HI]). It is not well established if patients who achieve SD at 4–6 months of t...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Leuk Res
Prif Awduron: Nazha, Aziz, Sekeres, Mikkael A., Garcia-Manero, Guillermo, Barnard, John, Al Ali, Najla H., Roboz, Gail J., Steensma, David P., DeZern, Amy E., Zimmerman, Cassie, Jabbour, Elias J., Zell, Katrina, List, Alan F., Kantarjian, Hagop M., Maciejewski, Jaroslaw P., Komrokji, Rami S.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2015
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4986515/
https://ncbi.nlm.nih.gov/pubmed/26777537
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.leukres.2015.12.007
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg